Kaiser, J. Customized tumour vaccines preserve most cancers in test. Science 356, 122 (2017).
Pulendran, B. & Davis, M. M. The science and medication of human immunology. Science 369, eaay4014 (2020).
Ci, T. et al. Cryo-shocked most cancers cells for focused drug supply and vaccination. Sci. Adv. 6, eabc3013 (2020).
Jiang, Y. et al. Engineered cell-membrane-coated nanoparticles immediately current tumor antigens to advertise anticancer immunity. Adv. Mater. 32, e2001808 (2020).
Guo, J. et al. Most cancers vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns. Nat. Biomed. Eng. 6, 19–31 (2022).
Harari, A., Graciotti, M., Bassani-Sternberg, M. & Kandalaft, L. E. Antitumour dendritic cell vaccination in a priming and boosting method. Nat. Rev. Drug Discov. 19, 635–652 (2020).
Marar, C., Starich, B. & Wirtz, D. Extracellular vesicles in immunomodulation and tumor development. Nat. Immunol. 22, 560–570 (2021).
Cheng, L. & Hill, A. F. Therapeutically harnessing extracellular vesicles. Nat. Rev. Drug Discov. 21, 379–399 (2022).
Jhunjhunwala, S., Hammer, C. & Delamarre, L. Antigen presentation in most cancers: insights into tumour immunogenicity and immune evasion. Nat. Rev. Most cancers 21, 298–312 (2021).
Roth, G. A. et al. Designing spatial and temporal management of vaccine responses. Nat. Rev. Mater. 7, 174–195 (2022).
Ma, L. et al. Immunotherapy and prevention of most cancers by nanovaccines loaded with whole-cell elements of tumor tissues or cells. Adv. Mater. 33, e2104849 (2021).
Saxena, M., van der Burg, S. H., Melief, C. J. M. & Bhardwaj, N. Therapeutic most cancers vaccines. Nat. Rev. Most cancers 21, 360–378 (2021).
Zhang, X., Cui, H., Zhang, W., Li, Z. & Gao, J. Engineered tumor cell-derived vaccines in opposition to most cancers: the artwork of combating poison with poison. Bioact. Mater. 22, 491–517 (2023).
Web page, D. B. et al. Glimpse into the long run: harnessing autophagy to advertise antitumour immunity with the DRibbles vaccine. J. Immunother. Most cancers 4, 25 (2016).
Wenger, T. et al. Autophagy inhibition promotes faulty neosynthesized proteins storage in ALIS, and induces redirection towards proteasome processing and MHCI-restricted presentation. Autophagy 8, 350–363 (2012).
Yi, Y. et al. Autophagy-assisted antigen cross-presentation: autophagosome because the argo of shared tumour-specific antigens and DAMPs. Oncoimmunology 1, 976–978 (2012).
Hou, W. et al. Unusual attractors: DAMPs and autophagy hyperlink tumor cell dying and immunity. Cell Demise Dis. 4, e966 (2013).
Yamamoto, Okay. et al. Autophagy promotes immune evasion of pancreatic most cancers by degrading MHC-I. Nature 581, 100–105 (2020).
MacNabb, B. W. et al. Dendritic cells can prime antitumour CD8+ T cell responses by main histocompatibility advanced cross-dressing. Immunity 55, 982–997.e8 (2022).
Dersh, D., Holly, J. & Yewdell, J. W. A number of good peptides: MHC class I-based most cancers immunosurveillance and immunoevasion. Nat. Rev. Immunol. 21, 116–128 (2021).
Li, Y. et al. Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy. Clin. Most cancers Res. 17, 7047–7057 (2011).
Li, Y. et al. Environment friendly cross-presentation is determined by autophagy in tumor cells. Most cancers Res. 68, 6889–6895 (2008).
Ye, Z. et al. Manipulation of PD-L1 endosomal trafficking promotes anticancer immunity. Adv. Sci. 10, e2206411 (2022).
Raudenska, M., Balvan, J. & Masarik, M. Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a problem for autophagy-based remedy of stable cancers. Mol. Most cancers 20, 140 (2021).
Wen, Z. F. et al. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression by induction of M2-like macrophages with elevated expression of PD-L1. J. Immunother. Most cancers 6, 151 (2018).
Sanborn, R. E. et al. A pilot research of an autologous tumor-derived autophagosome vaccine with docetaxel in sufferers with stage IV non-small cell lung most cancers. J. Immunother. Most cancers 5, 103 (2017).
Diao, L. & Liu, M. Rethinking antigen supply: most cancers vaccines based mostly on complete tumor cell/tissue lysate or complete tumor cell. Adv. Sci. 10, e2300121 (2023).
Wang, H. et al. GABARAPs regulate PI4P-dependent autophagosome:lysosome fusion. Proc. Natl Acad. Sci. USA 112, 7015–7020 (2015).
Solar, H. Q. et al. PI4P-dependent concentrating on of ATG14 to mature autophagosomes. Biochemistry 61, 722–729 (2022).
Cebollero, E. et al. Phosphatidylinositol-3-phosphate clearance performs a key position in autophagosome completion. Curr. Biol. 22, 1545–1553 (2012).
van Niel, G., D’Angelo, G. & Raposo, G. Shedding mild on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213–228 (2018).
Martens, S., Nakamura, S. & Yoshimori, T. Phospholipids in autophagosome formation and fusion. J. Mol. Biol. 428, 4819–4827 (2016).
Zhao, Y. G., Codogno, P. & Zhang, H. Equipment, regulation and pathophysiological implications of autophagosome maturation. Nat. Rev. Mol. Cell Biol. 22, 733–750 (2021).
Shinoda, S. et al. Syntaxin 17 recruitment to mature autophagosomes is temporally regulated by PI4P accumulation. eLife 12, RP92189 (2024).
Laczkó-Dobos, H. et al. PtdIns4P is required for the autophagosomal recruitment of STX17 (syntaxin 17) to advertise lysosomal fusion. Autophagy 20, 1639–1650 (2024).
Chen, D. et al. A mammalian autophagosome maturation mechanism mediated by TECPR1 and the Atg12-Atg5 conjugate. Mol. Cell 45, 629–641 (2012).
Nakamura, S. & Yoshimori, T. New insights into autophagosome–lysosome fusion. J. Cell Sci. 130, 1209–1216 (2017).
Johnson, D., Qiao, Z., Uwadiunor, E. & Djire, A. Holdups in nitride MXene’s improvement and limitations in advancing the sector of MXene. Small 18, e2106129 (2022).
Marino, G., Niso-Santano, M., Baehrecke, E. H. & Kroemer, G. Self-consumption: the interaction of autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 15, 81–94 (2014).
Debnath, J., Gammoh, N. & Ryan, Okay. M. Autophagy and autophagy-related pathways in most cancers. Nat. Rev. Mol. Cell Biol. 24, 560–575 (2023).
Clarke, A. J. & Simon, A. Okay. Autophagy within the renewal, differentiation and homeostasis of immune cells. Nat. Rev. Immunol. 19, 170–183 (2019).
Zhao, J. et al. In situ progress of nanoantioxidants on mobile vesicles for environment friendly reactive oxygen species elimination in acute inflammatory ailments. Nano Immediately 40, 101282 (2021).
Murshid, A., Gong, J., Stevenson, M. A. & Calderwood, S. Okay. Warmth shock proteins and most cancers vaccines: developments up to now decade and chaperoning within the decade to return. Skilled Rev. Vaccines 10, 1553–1568 (2011).
Lhuillier, C. et al. Radiotherapy-exposed CD8+ and CD4+ neoantigens improve tumor management. J. Clin. Make investments. 131, e138740 (2021).
Kreiter, S. et al. Mutant MHC class II epitopes drive therapeutic immune responses to most cancers. Nature 520, 692–696 (2015).
Qin, H. et al. Improvement of a most cancers vaccine utilizing in vivo click-chemistry-mediated energetic lymph node accumulation for improved immunotherapy. Adv. Mater. 33, e2006007 (2021).
Music, T. et al. Engineering the deformability of albumin-stabilized emulsions for lymph-node vaccine supply. Adv. Mater. 33, e2100106 (2021).
Gong, T., Liu, L., Jiang, W. & Zhou, R. DAMP-sensing receptors in sterile irritation and inflammatory ailments. Nat. Rev. Immunol. 20, 95–112 (2020).
Marichal, T. et al. DNA launched from dying host cells mediates aluminum adjuvant exercise. Nat. Med. 17, 996–1002 (2011).
Gou, S. et al. Engineered nanovaccine concentrating on Clec9a+ dendritic cells remarkably enhances the most cancers immunotherapy results of STING agonist. Nano Lett. 21, 9939–9950 (2021).
Xu, J. et al. A normal technique in direction of personalised nanovaccines based mostly on fluoropolymers for postsurgical most cancers immunotherapy. Nat. Nanotechnol. 15, 1043–1052 (2020).
Zhao, J. et al. A minimalist binary vaccine provider for personalised postoperative most cancers vaccine remedy. Adv. Mater. 34, e2109254 (2022).
Lin, Z. J., Zhuo, M. J., Li, M. S., Wang, J. Y. & Zhou, Y. C. Synthesis and microstructure of layered-ternary Ti2AlN ceramic. Scr. Mater. 56, 1115–1118 (2007).
